Larimar Therapeutics Inc. buy Lokrim
Start price
17.05.21
/
0%
€11.40
Target price
17.05.22
-
Performance (%)
-79.82%
End price
18.05.22
€2.30
Summary
This prediction ended on 18.05.22 with a price of €2.30. The BUY prediction by Lokrim for Larimar Therapeutics Inc. performed very badly with a performance of -79.82%. Lokrim has a follow-up prediction for Larimar Therapeutics Inc., but this time predicts that Larimar Therapeutics Inc. is a Sell. This prediction was marked as speculative and is excluded from Lokrim's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Larimar Therapeutics Inc. | 8.974% | 8.974% | -40.351% | -5.028% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to Lokrim what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Cons
Below average Marketposition
Probably not worthwhile Investment
Revenue decline/stagnation expected
Comments by Lokrim for this prediction
In the thread Zafgen Inc. diskutieren
Buy Larimar Therapeutics Inc.
In the thread Trading Zafgen Inc.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten
Current prediction by Lokrim for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.92
07.01.25
07.01.25
-
07.01.26
07.01.26
-12.76%
12.12.25
12.12.25
Below average Marketposition
